Loechner et al (15) reported a patient diagnosed with congenital hyperinsulinism (due to KCNJ11 gene mutation), who had hypertension and was treated with octreotide and amlodipine (a calcium-channel blocker). Here, KCNJ11 is linked to hyperinsulinism.